Skip to main content
Top
Published in: Clinical Rheumatology 2/2022

01-02-2022 | Systemic Lupus Erythematosus | Original Article

Prevalence, clinical features, risk factors, and outcomes of SLE patients with aortic aneurysm: a cross-sectional retrospective study in a Chinese single center

Authors: Ju Zhang, Jie Gao, Ruina Kong, Chenxin Cheng, Qian Chen, Yunxia Xia, Xiaofang Li, Ti Zhang, Qing Cai

Published in: Clinical Rheumatology | Issue 2/2022

Login to get access

Abstract

Objectives

The prevalence, clinical features, and outcomes of patients with systemic lupus erythematosus (SLE) complicated with or without aortic aneurysm (AA) were compared in a Chinese single-center cohort.

Methods

Included in this study were SLE patients who received treatment at Shanghai Changhai Hospital between 2000 and 2020. The prevalence, clinical features, and outcomes of these SLE patients with or without AA were compared by Student’s t-tests or Fisher’s exact tests as appropriate. Risk factors associated with AA occurrence in SLE were evaluated by univariable and multivariable logistic regression analyses. The survival analysis between SLE patients with or without AA was conducted by the Kaplan–Meier method.

Results

Of the 1843 SLE patients included in this study, 16 (0.86%) were identified as having AA, and 160 of the remaining 1825 SLE patients without AA were selected as a simple random sample for comparison. The SLE patients with AA showed a higher proportion of smoking and hypertension as compared with those with no AA. Multivariable logistic regression analysis showed that a long SLE duration and anti-RNP positivity were two independent risk factors associated with AA occurrence in SLE patients. The log rank test showed that SLE patients with AA had a significantly higher risk of progression to death. Renal disorder was associated with an even poorer outcome in SLE patients with AA.

Conclusion

The incidence of AA in SLE patients may be underestimated. The association between AA and SLE, especially in patients with multiple risk factors, should not be ignored.
Key Points
• The risk of SLE patients developing AA may be higher than that previously estimated.
• The risk of SLE patients especially with multiple risk factors developing AA should not be ignored.
• The diagnosis of AA should not be forgot when SLE patients present with chest, back, or abdominal symptoms with unexplained causes.
Literature
1.
go back to reference Urowitz MB, Ibañez D, Gladman DD (2007) Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 34:70–75PubMed Urowitz MB, Ibañez D, Gladman DD (2007) Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 34:70–75PubMed
2.
go back to reference Durcan L, O’Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393:2332–2343CrossRef Durcan L, O’Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393:2332–2343CrossRef
3.
go back to reference Dörner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393:2344–2358CrossRef Dörner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393:2344–2358CrossRef
4.
go back to reference Urowitz MB, Gladman DD, Farewell V, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri MA, Bruce IN, Khamashta MA, Aranow C, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Jönsen A, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Ỉnanç M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T (2020) Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort. Arthritis Rheumatol 72:1734–1740CrossRef Urowitz MB, Gladman DD, Farewell V, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri MA, Bruce IN, Khamashta MA, Aranow C, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Jönsen A, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Ỉnanç M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T (2020) Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort. Arthritis Rheumatol 72:1734–1740CrossRef
5.
go back to reference Tselios K, Gladman DD, Su J, Urowitz M (2020) Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. Ann Rheum Dis 79:612–617CrossRef Tselios K, Gladman DD, Su J, Urowitz M (2020) Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. Ann Rheum Dis 79:612–617CrossRef
6.
go back to reference Nienaber CA, Clough RE, Sakalihasan N, Suzuki T, Gibbs R, Mussa F, Jenkins MP, Thompson MM, Evangelista A, Yeh JS, Cheshire N, Rosendahl U, Pepper J (2016) Aortic dissection Nat Rev Dis Primers 2:16053CrossRef Nienaber CA, Clough RE, Sakalihasan N, Suzuki T, Gibbs R, Mussa F, Jenkins MP, Thompson MM, Evangelista A, Yeh JS, Cheshire N, Rosendahl U, Pepper J (2016) Aortic dissection Nat Rev Dis Primers 2:16053CrossRef
7.
go back to reference Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM (2011) Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 8:92–102CrossRef Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM (2011) Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 8:92–102CrossRef
8.
go back to reference Li Y, Yang N, Duan W, Liu S, Yu S, Yi D (2012) Acute aortic dissection in China. Am J Cardiol 110:1056–1061CrossRef Li Y, Yang N, Duan W, Liu S, Yu S, Yi D (2012) Acute aortic dissection in China. Am J Cardiol 110:1056–1061CrossRef
9.
go back to reference Guy A, Tiosano S, Comaneshter D, Tekes-Manova D, Shovman O, Cohen AD, Amital H (2016) Aortic aneurysm association with SLE - a case-control study. Lupus 25:959–963CrossRef Guy A, Tiosano S, Comaneshter D, Tekes-Manova D, Shovman O, Cohen AD, Amital H (2016) Aortic aneurysm association with SLE - a case-control study. Lupus 25:959–963CrossRef
10.
go back to reference Kermani TA, Warrington KJ, Crowson CS, Hunder GG, Ytterberg SR, Gabriel SE, Matteson EL (2016) Predictors of dissection in aortic aneurysms from giant cell arteritis. J Clin Rheumatol 22:184–187CrossRef Kermani TA, Warrington KJ, Crowson CS, Hunder GG, Ytterberg SR, Gabriel SE, Matteson EL (2016) Predictors of dissection in aortic aneurysms from giant cell arteritis. J Clin Rheumatol 22:184–187CrossRef
11.
go back to reference Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG (2004) Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 83:335–341CrossRef Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG (2004) Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 83:335–341CrossRef
12.
go back to reference Silvestri V, Simonte G. 2017. Aortic Pathology in Systemic Lupus Erythematosus: A Case Report and Review of Literature. Ann Vasc Surg 43:312 e5–312 e12. Silvestri V, Simonte G. 2017. Aortic Pathology in Systemic Lupus Erythematosus: A Case Report and Review of Literature. Ann Vasc Surg 43:312 e5–312 e12.
13.
go back to reference Li J, Wang X, Zhang H, Wang W, Pei Y, Xie T, Lin W, Zuo X, Zhang W (2019) Aorta coarctation and systemic lupus erythematosus: a case report. Medicine (Baltimore) 98:e16397CrossRef Li J, Wang X, Zhang H, Wang W, Pei Y, Xie T, Lin W, Zuo X, Zhang W (2019) Aorta coarctation and systemic lupus erythematosus: a case report. Medicine (Baltimore) 98:e16397CrossRef
14.
go back to reference Yuan SM (2019) Aortic aneurysm and dissection in systemic lupus erythematosus. Z Rheumatol 78:287–294CrossRef Yuan SM (2019) Aortic aneurysm and dissection in systemic lupus erythematosus. Z Rheumatol 78:287–294CrossRef
15.
go back to reference Petri M, Genovese M, Engle E, Hochberg M (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study Arthritis Rheum 34:937–944PubMed Petri M, Genovese M, Engle E, Hochberg M (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study Arthritis Rheum 34:937–944PubMed
16.
go back to reference Griffiths B, Mosca M, Gordon C (2005) Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 19:685–708CrossRef Griffiths B, Mosca M, Gordon C (2005) Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 19:685–708CrossRef
17.
go back to reference Cook RJ, Gladman DD, Pericak D, Urowitz MB (2000) Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 27:1892–1895PubMed Cook RJ, Gladman DD, Pericak D, Urowitz MB (2000) Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 27:1892–1895PubMed
18.
go back to reference Gladman DD, Urowitz MB, Kagal A, Hallett D (2000) Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 27:377–379PubMed Gladman DD, Urowitz MB, Kagal A, Hallett D (2000) Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 27:377–379PubMed
19.
go back to reference Bennett SJ, Dill KE, Hanley M, Ahmed O, Desjardins B, Gage KL, Ginsburg M, Khoynezhad A, Oliva IB, Steigner ML, Strax R, Verma N, Rybicki FJ (2018) ACR Appropriateness Criteria(®) suspected thoracic aortic aneurysm. J Am Coll Radiol 15:S208-s214CrossRef Bennett SJ, Dill KE, Hanley M, Ahmed O, Desjardins B, Gage KL, Ginsburg M, Khoynezhad A, Oliva IB, Steigner ML, Strax R, Verma N, Rybicki FJ (2018) ACR Appropriateness Criteria(®) suspected thoracic aortic aneurysm. J Am Coll Radiol 15:S208-s214CrossRef
20.
go back to reference Barile-Fabris L, Hernández-Cabrera MF, Barragan-Garfias JA (2014) Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep 16:440CrossRef Barile-Fabris L, Hernández-Cabrera MF, Barragan-Garfias JA (2014) Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep 16:440CrossRef
21.
go back to reference Wang SH, Chang YS, Liu CJ, Lai CC, Chen TJ, Chen WS (2014) Incidence and risk analysis of aortic aneurysm and aortic dissection among patients with systemic lupus erythematosus: a nationwide population-based study in Taiwan. Lupus 23:665–671CrossRef Wang SH, Chang YS, Liu CJ, Lai CC, Chen TJ, Chen WS (2014) Incidence and risk analysis of aortic aneurysm and aortic dissection among patients with systemic lupus erythematosus: a nationwide population-based study in Taiwan. Lupus 23:665–671CrossRef
22.
go back to reference Roldan PC, Ratliff M, Snider R, Macias L, Rodriguez R, Sibbitt W, Roldan CA. 2014. Aortic atherosclerosis in systemic lupus erythematosus. Rheumatology (Sunnyvale) Suppl 5. Roldan PC, Ratliff M, Snider R, Macias L, Rodriguez R, Sibbitt W, Roldan CA. 2014. Aortic atherosclerosis in systemic lupus erythematosus. Rheumatology (Sunnyvale) Suppl 5.
23.
go back to reference Wang W, Duan W, Xue Y, Wang L, Liu J, Yu S, Yi D, Registry of Aortic Dissection in China Sino RADI. (2014) Clinical features of acute aortic dissection from the Registry of Aortic Dissection in China. J Thorac Cardiovasc Surg 148:2995–3000CrossRef Wang W, Duan W, Xue Y, Wang L, Liu J, Yu S, Yi D, Registry of Aortic Dissection in China Sino RADI. (2014) Clinical features of acute aortic dissection from the Registry of Aortic Dissection in China. J Thorac Cardiovasc Surg 148:2995–3000CrossRef
24.
go back to reference Kurata A, Kawakami T, Sato J, Sakamoto A, Muramatsu T, Nakabayashi K (2011) Aortic aneurysms in systemic lupus erythematosus: a meta-analysis of 35 cases in the literature and two different pathogeneses. Cardiovasc Pathol 20:e1-7CrossRef Kurata A, Kawakami T, Sato J, Sakamoto A, Muramatsu T, Nakabayashi K (2011) Aortic aneurysms in systemic lupus erythematosus: a meta-analysis of 35 cases in the literature and two different pathogeneses. Cardiovasc Pathol 20:e1-7CrossRef
25.
go back to reference Ohara N, Miyata T, Kurata A, Oshiro H, Sato O, Shigematsu H (2000) Ten years’ experience of aortic aneurysm associated with systemic lupus erythematosus. Eur J Vasc Endovasc Surg 19:288–293CrossRef Ohara N, Miyata T, Kurata A, Oshiro H, Sato O, Shigematsu H (2000) Ten years’ experience of aortic aneurysm associated with systemic lupus erythematosus. Eur J Vasc Endovasc Surg 19:288–293CrossRef
26.
go back to reference Di Battista M, Tani C, Elefante E, Chimera D, Carli L, Ferro F, Stagnaro C, Mosca M (2020) Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation? Clin Exp Rheumatol 38:602–608PubMed Di Battista M, Tani C, Elefante E, Chimera D, Carli L, Ferro F, Stagnaro C, Mosca M (2020) Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation? Clin Exp Rheumatol 38:602–608PubMed
27.
go back to reference Dima A, Jurcut C, Baicus C (2018) The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int 38:1169–1178CrossRef Dima A, Jurcut C, Baicus C (2018) The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int 38:1169–1178CrossRef
28.
go back to reference Quintana RA, Taylor WR (2019) Cellular mechanisms of aortic aneurysm formation. Circ Res 124:607–618CrossRef Quintana RA, Taylor WR (2019) Cellular mechanisms of aortic aneurysm formation. Circ Res 124:607–618CrossRef
30.
go back to reference Golledge J (2019) Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol 16:225–242CrossRef Golledge J (2019) Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol 16:225–242CrossRef
Metadata
Title
Prevalence, clinical features, risk factors, and outcomes of SLE patients with aortic aneurysm: a cross-sectional retrospective study in a Chinese single center
Authors
Ju Zhang
Jie Gao
Ruina Kong
Chenxin Cheng
Qian Chen
Yunxia Xia
Xiaofang Li
Ti Zhang
Qing Cai
Publication date
01-02-2022
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 2/2022
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-05927-w

Other articles of this Issue 2/2022

Clinical Rheumatology 2/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.